# COMPASS Pathways plc: filings

CMPS · Nasdaq · CIK 1816590 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cmps.md) · [Financials](/companies/cmps/financials.md) · [Filings](/companies/cmps/filings.md) · [Insiders](/companies/cmps/insiders.md)

## Reports and events: 103 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 115, 8-K 48, 6-K 23, 3 21, 10-Q 14, SCHEDULE 13G/A 11, CORRESP 9, S-8 8, SC 13G 8, EFFECT 7, 144 6, 424B5 6, SC 13G/A 6, UPLOAD 6, 10-K 5, DEF 14A 5, ARS 4, SCHEDULE 13G 4, S-3 3, SC 13D/A 3, SCHEDULE 13D/A 3, 424B4 2, DRS 2, F-1 2, F-1/A 2, F-1MEF 2, PRE 14A 2, 20-F 1, 424B3 1, 4/A 1, 8-A12B 1, CERT 1, DRS/A 1, DRSLTR 1, F-3ASR 1, F-6 1, F-6/A 1, F-6EF 1, POS AM 1, POSASR 1, S-3ASR 1, SC 13D 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-05 | 06:31 ET | [8-K](/filings/0001816590-26-000059.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001816590-26-000059 |
| 2026-08-05 | 06:30 ET | [10-Q](/filings/0001816590-26-000058.md) | Quarterly report, period 2026-06-30 | 0001816590-26-000058 |
| 2026-07-07 | 06:33 ET | [8-K](/filings/0001816590-26-000047.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001816590-26-000047 |
| 2026-05-28 | 06:43 ET | [8-K](/filings/0001816590-26-000046.md) | 5.07 Shareholder vote results | 0001816590-26-000046 |
| 2026-05-13 | 06:30 ET | [8-K](/filings/0001816590-26-000043.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001816590-26-000043 |
| 2026-05-13 | 06:30 ET | [10-Q](/filings/0001816590-26-000042.md) | Quarterly report, period 2026-03-31 | 0001816590-26-000042 |
| 2026-04-15 | 16:32 ET | [DEF 14A](/filings/0001193125-26-157123.md) | Proxy statement, period 2026-05-27 | 0001193125-26-157123 |
| 2026-03-24 | 07:30 ET | [10-K](/filings/0001816590-26-000020.md) | Annual report, period 2025-12-31 | 0001816590-26-000020 |
| 2026-03-24 | 07:30 ET | [8-K](/filings/0001816590-26-000021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001816590-26-000021 |
| 2026-02-19 | 08:50 ET | [8-K](/filings/0001628280-26-009501.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-009501 |
| 2026-02-17 | 16:46 ET | [SCHEDULE 13D/A](/filings/0001140361-26-005810.md) | Ownership report, active investor, amended | 0001140361-26-005810 |
| 2026-02-17 | 06:33 ET | [8-K](/filings/0001816590-26-000007.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001816590-26-000007 |
| 2026-01-07 | 06:35 ET | [8-K](/filings/0001816590-26-000004.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001816590-26-000004 |
| 2025-11-04 | 06:30 ET | [10-Q](/filings/0001816590-25-000150.md) | Quarterly report, period 2025-09-30 | 0001816590-25-000150 |
| 2025-11-04 | 06:30 ET | [8-K](/filings/0001816590-25-000149.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001816590-25-000149 |
| 2025-10-29 | 18:15 ET | [SCHEDULE 13D/A](/filings/0001140361-25-039738.md) | Ownership report, active investor, amended | 0001140361-25-039738 |
| 2025-10-29 | 06:34 ET | [8-K](/filings/0001816590-25-000141.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001816590-25-000141 |
| 2025-07-31 | 06:31 ET | [8-K](/filings/0001816590-25-000103.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001816590-25-000103 |
| 2025-07-31 | 06:30 ET | [10-Q](/filings/0001816590-25-000102.md) | Quarterly report, period 2025-06-30 | 0001816590-25-000102 |
| 2025-07-29 | 06:40 ET | [8-K](/filings/0001816590-25-000094.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001816590-25-000094 |
| 2025-06-23 | 06:32 ET | [8-K](/filings/0001816590-25-000085.md) | 8.01 Other events | 0001816590-25-000085 |
| 2025-06-13 | 08:14 ET | [8-K](/filings/0001816590-25-000067.md) | 5.07 Shareholder vote results | 0001816590-25-000067 |
| 2025-05-08 | 06:39 ET | [8-K](/filings/0001628280-25-023427.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-023427 |
| 2025-05-08 | 06:38 ET | [10-Q](/filings/0001628280-25-023426.md) | Quarterly report, period 2025-03-31 | 0001628280-25-023426 |
| 2025-04-28 | 08:19 ET | [DEF 14A](/filings/0001816590-25-000051.md) | Proxy statement, period 2025-04-28 | 0001816590-25-000051 |
| 2025-04-16 | 08:34 ET | [8-K](/filings/0001816590-25-000042.md) | 4.01 Change of auditor; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001816590-25-000042 |
| 2025-03-05 | 16:36 ET | [SCHEDULE 13D/A](/filings/0001140361-25-007214.md) | Ownership report, active investor, amended | 0001140361-25-007214 |
| 2025-02-27 | 06:29 ET | [8-K](/filings/0001628280-25-008414.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-008414 |
| 2025-02-27 | 06:28 ET | [10-K](/filings/0001628280-25-008412.md) | Annual report, period 2024-12-31 | 0001628280-25-008412 |
| 2025-01-10 | 07:06 ET | [8-K](/filings/0001816590-25-000008.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001816590-25-000008 |
| 2024-10-31 | 06:30 ET | [8-K](/filings/0001628280-24-044400.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-044400 |
| 2024-10-31 | 06:30 ET | [10-Q](/filings/0001628280-24-044398.md) | Quarterly report, period 2024-09-30 | 0001628280-24-044398 |
| 2024-09-27 | 19:56 ET | [SC 13D/A](/filings/0001140361-24-042244.md) | Ownership report, active investor, amended | 0001140361-24-042244 |
| 2024-08-01 | 06:31 ET | [8-K](/filings/0001628280-24-033854.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-24-033854 |
| 2024-08-01 | 06:30 ET | [10-Q](/filings/0001628280-24-033853.md) | Quarterly report, period 2024-06-30 | 0001628280-24-033853 |
| 2024-05-09 | 17:28 ET | [8-K](/filings/0001816590-24-000086.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001816590-24-000086 |
| 2024-05-08 | 06:46 ET | [8-K](/filings/0001628280-24-021352.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-021352 |
| 2024-05-08 | 06:45 ET | [10-Q](/filings/0001628280-24-021351.md) | Quarterly report, period 2024-03-31 | 0001628280-24-021351 |
| 2024-05-08 | 06:34 ET | [8-K](/filings/0001816590-24-000083.md) | 8.01 Other events | 0001816590-24-000083 |
| 2024-04-08 | 07:58 ET | [DEF 14A](/filings/0001816590-24-000070.md) | Proxy statement, period 2024-04-08 | 0001816590-24-000070 |
| 2024-03-28 | 08:01 ET | [8-K](/filings/0001628280-24-013452.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-24-013452 |
| 2024-02-29 | 07:00 ET | [8-K](/filings/0001628280-24-007788.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-007788 |
| 2024-02-29 | 06:59 ET | [10-K](/filings/0001628280-24-007787.md) | Annual report, period 2023-12-31 | 0001628280-24-007787 |
| 2023-12-07 | 07:02 ET | [8-K](/filings/0001816590-23-000142.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001816590-23-000142 |
| 2023-11-02 | 07:04 ET | [8-K](/filings/0001628280-23-036181.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-036181 |
| 2023-11-02 | 07:00 ET | [10-Q](/filings/0001628280-23-036170.md) | Quarterly report, period 2023-09-30 | 0001628280-23-036170 |
| 2023-10-26 | 08:04 ET | [8-K](/filings/0001816590-23-000131.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001816590-23-000131 |
| 2023-09-18 | 16:35 ET | [8-K](/filings/0001816590-23-000123.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001816590-23-000123 |
| 2023-08-16 | 09:08 ET | [8-K](/filings/0001816590-23-000104.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001816590-23-000104 |
| 2023-08-03 | 07:00 ET | [8-K](/filings/0001628280-23-026987.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-23-026987 |

Page 1 of 3. [Older](/companies/cmps/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 28, 2026, 10:12 ET. No prices; not investment advice.